Skip to Content

Join the 'Desmopressin' group to help and get support from people like you.

Desmopressin News

FDA Approves Noctiva (desmopressin acetate) Nasal Spray for Nocturia in Adults

Posted 4 Mar 2017 by Drugs.com

March 3, 2017 – The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). Noctiva is the first FDA-approved treatment for this condition. “Today’s approval provides adults who overproduce urine at night with the first FDA-approved therapeutic option to help reduce the number of times a night they wake up to urinate,” said Hylton V. Joffe, M.D., M.M.Sc., director of the Division of Bone, Reproductive, and Urologic Products in the FDA’s Center for Drug Evaluation and Research. “It is important to know that Noctiva is not approved for all causes of night-time urination, so patients should discuss their symptoms with their health care provider who can determine the underlying cause of the night-time ur ... Read more

Related support groups: Desmopressin, Nocturnal Polyuria, Noctiva

Could Nasal Spray Curtail Nighttime Bathroom Trips?

Posted 8 May 2016 by Drugs.com

SUNDAY, May 8, 2016 – Countless people – often men with enlarged prostates – need to visit the bathroom during the night. But help could soon be at hand in the form of a nasal spray, new research suggests. A spritz of a synthetic hormone, already used by bed-wetting kids, might benefit older people struggling with the problem called nocturia. "Nocturia is very common in patients over 50 years old, and can cause significant problems by causing loss of sleep, and injury due to falls," said study lead author Dr. Jed Kaminetsky. The millions of people with nocturia wake up two or more times a night to urinate. Besides an enlarged prostate, Kaminetsky said, common causes are bladder problems, poor circulation and obesity. Kaminetsky is a clinical assistant professor of urology at NYU Langone Medical Center in New York City. In the United States there's no approved drug to treat the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostatitis, Desmopressin, DDAVP, Minirin, Primary Nocturnal Enuresis, DDAVP Nasal, DDAVP Rhinal Tube, Stimate, Nocturnal Polyuria, Prostate Tumor - Benign

Simple Strategies Aren't Always Enough for Bedwetting

Posted 27 Aug 2013 by Drugs.com

TUESDAY, Aug. 27 – While techniques such as fluid restriction can help some children who have problems with bedwetting, alarms and medications are more effective, a new study finds. "Simple behavioral therapies such as rewarding the child for dry nights or taking the child to the toilet during the night can sometimes help with bedwetting, and is better than doing nothing," said study leader Dr. Patrina Caldwell, a pediatrician at the Children's Hospital at Westmead and senior lecturer at the University of Sydney, in Australia. "However, there are more effective treatments such as bedwetting alarm training or medications," she said. But alarm training is more difficult, she noted. Bedwetting affects about 5 million children in the United States, with up to 20 percent of 5-year-olds having the problem. Most kids outgrow the problem, known medically as nocturnal enuresis, and only 2 ... Read more

Related support groups: Imipramine, Desmopressin, Tofranil, DDAVP, Minirin, Primary Nocturnal Enuresis, DDAVP Nasal, DDAVP Rhinal Tube, Stimate, Tofranil-PM

Ask a Question

Further Information

Related Condition Support Groups

von Willebrand's Disease, Diabetes Insipidus, Primary Nocturnal Enuresis, Nocturnal Polyuria, Hemophilia A

Related Drug Support Groups

DDAVP, Minirin, DDAVP Nasal, Stimate, DDAVP Rhinal Tube, Noctiva

Desmopressin Patient Information at Drugs.com